Ani Pharmaceuticals director Thoma sells $71,530 in shares

ANI Pharmaceuticals director Jeanne Thoma sold 1,000 shares of the company's common stock on September 11, 2026, at a price of $71.53 per share, totaling $71,530. This sale was conducted pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. Thoma currently holds 26,762 shares of ANI Pharmaceuticals common stock. The stock is trading near its 52-week low of $69.58, currently at $70.40, and is considered undervalued by InvestingPro analysis.

Despite strong second-quarter 2026 results, with adjusted earnings of $2.21 per share and record revenue of $266 million, analysts have mixed opinions on the company's outlook, with some revising price targets and others maintaining a Hold rating.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.